Daniel A. Vazquez-Carrillo

Mexico City, DIF 14080, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Disrupted Neutrophil and Myeloid Cell Homeostasis and Effector Dysfunction Drive Vasculopathy in Idiopathic Inflammatory Myopathies.

Disrupted Neutrophil and Myeloid Cell Homeostasis and Effector Dysfunction Drive Vasculopathy in Idiopathic Inflammatory Myopathies.

Journal: Cells

Published: March 12, 2026

Clinical, immunological and metabolomic risk factors associated with fibromyalgia in a cohort of patients with idiopathic inflammatory myopathies.

Clinical, immunological and metabolomic risk factors associated with fibromyalgia in a cohort of patients with idiopathic inflammatory myopathies.

Journal: Frontiers in immunology

Published: January 13, 2026

Risk Factors Associated with the Development of Thrombotic Microangiopathy in Patients with Dermatomyositis.

Risk Factors Associated with the Development of Thrombotic Microangiopathy in Patients with Dermatomyositis.

Journal: International journal of molecular sciences

Published: September 15, 2025

Dermatomyositis-Related Encephalopathy: Clinical, Neuroimaging and Immunological Characterization.

Dermatomyositis-Related Encephalopathy: Clinical, Neuroimaging and Immunological Characterization.

Journal: Diagnostics (Basel, Switzerland)

Published: December 16, 2024

Characterization of anti-neutrophil extracellular traps (NET) antibodies according to systemic lupus erythematosus clinical phenotypes.

Characterization of anti-neutrophil extracellular traps (NET) antibodies according to systemic lupus erythematosus clinical phenotypes.

Journal: Immunologic research

Published: November 02, 2024

Urine Extracellular Vesicles Size Subsets as Lupus Nephritis Biomarkers.

Urine Extracellular Vesicles Size Subsets as Lupus Nephritis Biomarkers.

Journal: Diagnostics (Basel, Switzerland)

Published: July 29, 2024

Disease activity is associated with changes in the innate immune function in patients with systemic lupus erythematosus.

Disease activity is associated with changes in the innate immune function in patients with systemic lupus erythematosus.

Journal: Clinical rheumatology

Published: June 21, 2023

Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals.

Systemic inflammation and cortical neurochemistry in never-medicated first episode-psychosis individuals.

Journal: Brain, behavior, and immunity

Published: December 21, 2022

Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus.

Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus.

Journal: Frontiers in immunology

Published: October 25, 2022

CD11c+ T-bet+ CD21hi B Cells Are Negatively Associated With Renal Impairment in Systemic Lupus Erythematosus and Act as a Marker for Nephritis Remission.

CD11c+ T-bet+ CD21hi B Cells Are Negatively Associated With Renal Impairment in Systemic Lupus Erythematosus and Act as a Marker for Nephritis Remission.

Journal: Frontiers in immunology

Published: March 08, 2022

Low-Density Granulocytes and Neutrophil Extracellular Traps as Biomarkers of Disease Activity in Adult Inflammatory Myopathies.

Low-Density Granulocytes and Neutrophil Extracellular Traps as Biomarkers of Disease Activity in Adult Inflammatory Myopathies.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: October 13, 2021

Prospective predictive performance comparison between clinical gestalt and validated COVID-19 mortality scores.

Prospective predictive performance comparison between clinical gestalt and validated COVID-19 mortality scores.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Published: September 15, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026